Financials
- Market Capitalization 485.74 M
- Employee 179
- Founded 2007
- CEO N/A
- Website www.pumabiotechnology.com
- Headquarter Delaware, United States
- FIGI BBG0018YXYX7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
15.6
市销率
1.8
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2917 | AGMB AgomAb Therapeutics NV - ADRs representing one | 14.75 USD | +7.98% | +6.58% | +7.27% | +0.34% | 503.97 M USD | ||
| 2926 | PRTA Prothena Corporation plc - Ordinary Shares | 9.60 USD | -0.93% | +6.43% | +14.42% | +13.61% | 492.83 M USD | ||
| 2949 | EDIT Editas Medicine, Inc. - Common Stock | 3.08 USD | 0.00% | -5.23% | +14.50% | +21.26% | 473.03 M USD | ||
| 2955 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.83 USD | +2.28% | +6.97% | +26.46% | +81.62% | 467.59 M USD |